Dr. Hafron discusses the use of oral Relugolix in prostate cancer
Document Type
Multimedia
Publication Date
4-29-2023
Publication Title
Urology Times
Recommended Citation
Hafron JM. Dr. Hafron discusses the use of oral Relugolix in prostate cancer. Urology Times 2023 Apr 29: https://www.urologytimes.com/view/dr-hafron-discusses-the-use-of-oral-relugolix-in-prostate-cancer
COinS